UBS raises Colgate-Palmolive India stock rating to buy

Published 21/04/2025, 17:02
UBS raises Colgate-Palmolive India stock rating to buy

On Monday, UBS analyst Amit Sachdeva changed the stock rating of Colgate-Palmolive (NYSE:CL) India (CLGT:IN) from Sell to Buy, significantly raising the price target to INR 3,100.00 from the previous INR 2,240.00. The upgrade follows a notable decline in the company’s share price, which UBS now deems to present an attractive valuation for investors.

Sachdeva’s comments highlighted an improving outlook for Colgate-Palmolive India, pointing to several factors that underpin the positive rating. Despite current weak demand, the analyst anticipates a turning point in earnings growth. One of the primary reasons for the optimism is the company’s increasing market share and its strengthened position as an oral-care specialist, which is evident from a 6% volume growth in the third quarter of fiscal year 2025.

The report also suggests that the recent margin reset and subdued earnings are temporary. Colgate-Palmolive India’s focus on premium product volumes is expected to lead to a robust earnings recovery starting in the second quarter of fiscal year 2026. Additionally, the potential for Colgate to capitalize on quick commerce is seen as an opportunity for the company to outpace its competitors in terms of investment.

UBS projects that the earnings per share (EPS) for Colgate-Palmolive India will accelerate from a growth rate of 7% in FY25E to a compound annual growth rate (CAGR) of 10% over FY25-27E. This anticipated growth is cited as a potential catalyst for the stock. The revised price target and upgraded rating reflect UBS’s confidence in the company’s prospects for the coming years.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.